See more : Bal Pharma Limited (BALPHARMA.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Lyckegård Group AB (publ) (LYGRD.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Lyckegård Group AB (publ), a leading company in the Agricultural – Machinery industry within the Industrials sector.
- Rudrabhishek Enterprises Limited (REPL.NS) Income Statement Analysis – Financial Results
- New Dazheng Property Group Co., Ltd. (002968.SZ) Income Statement Analysis – Financial Results
- Tonze New Energy Technology Co.,Ltd. (002759.SZ) Income Statement Analysis – Financial Results
- PD-Rx Pharmaceuticals, Inc. (PDRX) Income Statement Analysis – Financial Results
- Sylogist Ltd. (SYZLF) Income Statement Analysis – Financial Results
Lyckegård Group AB (publ) (LYGRD.ST)
About Lyckegård Group AB (publ)
Lyckegård Group AB (publ) develops, markets, and sells mechanical tools for sustainable agriculture market in Sweden, Norway, and Finland. It offers cameleon, quick witted, crimper roller, combcut, the bional, treffle, cookerling, and exchange machine tools, as well as Düvelsdorf and Suire agricultural machineries for sowing, tillage, and mechanical weed control. The company was formerly known as Just Common Sense AB and changed its name to Lyckegård Group AB (publ) in March 2019. Lyckegård Group AB (publ) was founded in 2008 and is headquartered in Staffanstorp, Sweden.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 165.19M | 54.30M | 39.11M | 13.21M | 6.67M | 8.75M |
Cost of Revenue | 93.85M | 74.91M | 50.60M | 15.20M | 10.16M | 10.32M |
Gross Profit | 71.34M | -20.60M | -11.49M | -1.99M | -3.49M | -1.57M |
Gross Profit Ratio | 43.19% | -37.94% | -29.39% | -15.04% | -52.30% | -17.91% |
Research & Development | 137.32K | 0.00 | 0.00 | 475.49K | 802.38K | 802.38K |
General & Administrative | 0.00 | 17.27M | 9.75M | 3.42M | 3.20M | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 0.00 | 17.27M | 9.75M | 3.42M | 3.20M | 0.00 |
Other Expenses | 109.82M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 109.96M | 42.96M | 26.96M | 475.49K | 802.38K | 802.38K |
Cost & Expenses | 203.81M | 74.91M | 50.60M | 15.20M | 10.96M | 11.12M |
Interest Income | 237.61K | 49.10K | 857.85K | 1.13K | 272.00 | 0.00 |
Interest Expense | 3.37M | 3.06M | 2.62M | 296.12K | 240.13K | 208.58K |
Depreciation & Amortization | 14.80M | 6.18M | 4.66M | 274.99K | 16.24K | 22.00K |
EBITDA | -23.58M | -12.80M | -5.47M | -1.43M | -4.27M | -1.69M |
EBITDA Ratio | -14.27% | -26.55% | -17.48% | -12.96% | -64.08% | -26.83% |
Operating Income | -38.61M | -20.60M | -11.49M | -1.99M | -4.29M | -2.37M |
Operating Income Ratio | -23.38% | -37.94% | -29.39% | -15.04% | -64.32% | -27.08% |
Total Other Income/Expenses | -3.13M | -3.01M | -1.76M | -296.12K | -64.86K | 447.71K |
Income Before Tax | -41.75M | -22.05M | -12.75M | -3.12M | -4.36M | -1.92M |
Income Before Tax Ratio | -25.27% | -40.60% | -32.60% | -23.62% | -65.30% | -21.96% |
Income Tax Expense | 2.75M | 235.25K | -1.47M | -110.19K | -4.00 | 1.00 |
Net Income | -44.50M | -22.29M | -11.28M | -3.01M | -4.36M | -1.92M |
Net Income Ratio | -26.94% | -41.04% | -28.84% | -22.79% | -65.30% | -21.96% |
EPS | -1.24 | -1.32 | -0.73 | -0.19 | -0.28 | -0.12 |
EPS Diluted | -1.24 | -1.32 | -0.73 | -0.19 | -0.28 | -0.12 |
Weighted Avg Shares Out | 35.90M | 16.89M | 15.52M | 15.52M | 15.52M | 15.52M |
Weighted Avg Shares Out (Dil) | 35.90M | 16.89M | 15.52M | 15.52M | 15.52M | 15.52M |
Source: https://incomestatements.info
Category: Stock Reports